semaglutide supply issues Dr Reddy's Shares Tumble Over Disruption Concerns Dr Reddy's Laboratories recorded its worst weekly stock performance in three years after announcing disruptions in the supply of its generic semaglutide drug Dr Reddy's Shares Sink 6%
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



























